Literature DB >> 28845030

On What Day of Illness Does the Dilatation of Coronary Arteries in Patients With Kawasaki Disease Begin?

Shigeto Fuse1, Toshihiko Mori1, Yuki Kuroiwa1, Satoshi Hirakawa1.   

Abstract

BACKGROUND: In the present study we used echocardiography to investigate coronary artery diameter at the time of diagnosis of Kawasaki disease (KD), before the start of treatment.Methods and 
Results: Diameters of the right, left main, left anterior descending, and left circumflex coronary arteries were determined in 410 patients before KD treatment commenced. The maximum Z-score was considered to be the pretreatment, maximum coronary artery Z-score (preZmax). The cumulative probability of coronary arterial dilatation was analyzed using the Kaplan-Meier method. In the present study, 31 patients (7.6%) had a preZmax ≥3.0, 56 (13.7%) had a preZmax ≥2.5, and 96 (23.4%) had a preZmax ≥2.0. The cumulative probability of a preZmax ≥2.0 was >20% on Day 5 of illness, 40% on Day 7, and 70% on Day 10. The positive predictive value (PPV) of a preZmax of 2.0 was approximately 0.9 on Day 5 of illness.
CONCLUSIONS: The present study demonstrates that the coronary arteries may dilate before Day 5 of illness, and that the rate of dilatation increases gradually until Day 10. Because preZmax 2.0 has high PPV after Day 5 of illness, it is a useful marker of coronary artery dilatation in the early phase of KD.

Entities:  

Keywords:  Coronary artery disease; Echocardiography; Kawasaki disease; Pediatrics

Mesh:

Year:  2017        PMID: 28845030     DOI: 10.1253/circj.CJ-17-0046

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  2 in total

1.  Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease.

Authors:  Yunjia Tang; Miao Gang; Weiguo Qian; Jin Ma; Qiuqin Xu; Haitao Lv
Journal:  Front Pediatr       Date:  2021-06-04       Impact factor: 3.418

2.  Value of serial echocardiography in diagnosing Kawasaki's disease.

Authors:  Maria Hörl; Holger Michel; Stephan Döring; Markus-Johann Dechant; Florian Zeman; Michael Melter; Stephan Gerling
Journal:  Eur J Pediatr       Date:  2020-09-21       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.